1-3 of 3
David Claxton
Close
Sort by
Journal Articles

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Clinical Trials & Observations
Sergio Giralt, Peter F. Thall, Issa Khouri, Xuemei Wang, Ira Braunschweig, Cindy Ippolitti, David Claxton, Michele Donato, Jill Bruton, Agueda Cohen, Marilyn Davis, Borje S. Andersson, Paolo Anderlini, James Gajewski, Steven Kornblau, Michael Andreeff, Donna Przepiorka, Naoto T. Ueno, Jeff Molldrem, Richard Champlin
Journal: Blood
Blood (2001) 97 (3): 631–637.
https://doi.org/10.1182/blood.V97.3.631
Published: 2001
Journal Articles

Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

Donna Przepiorka, Terry L. Smith, Jody Folloder, Issa Khouri, Naoto T. Ueno, Rakesh Mehra, Martin Körbling, Yang O. Huh, Sergio Giralt, James Gajewski, Michele Donato, Karen Cleary, David Claxton, Ira Braunschweig, Koen van Besien, Borje S. Andersson, Paolo Anderlini, Richard Champlin
Journal: Blood
Blood (1999) 94 (4): 1465–1470.
https://doi.org/10.1182/blood.V94.4.1465
Published: 1999
Journal Articles

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu Estey, Maher Albitar, Koen van Besien, Gabriela Rondón, Paolo Anderlini, Susan O'Brien, Issa Khouri, James Gajewski, Rakesh Mehra, David Claxton, Borje Andersson, Miloslav Beran, Donna Przepiorka, Charles Koller, Steve Kornblau, Martin Körbling, Michael Keating, Hagop Kantarjian, Richard Champlin
Journal: Blood
Blood (1997) 89 (12): 4531–4536.
https://doi.org/10.1182/blood.V89.12.4531
Published: 1997